Magstim Gets FDA’s 510(k) Clearance for Advanced Transcranial Magnetic Stimulation

Magstim has received the FDA’s 510(k) clearance for its Horizon 3.0. navigated transcranial magnetic stimulation (TMS) device.

The brain-stimulation device uses an electromagnetic coil to stimulate nerve cells in the region of the brain involved in mood control and depression.

It is designed for use along with Magstim Connect, a patient data management system for TMS that provides connected care at networked sites.

The Horizon 3.0 includes the company’s StimGuide+ navigation system, the first FDA-cleared TMS navigation system for the clinical setting, which provides quality control analytics and workflow improvements.